Neurodegeneration

FDA issues warnings on illegal Alzheimer’s drugs

2880 1920 Peter Stevenson, PhD

On 11 February 2019, the United States Food and Drug Administration (FDA) issued warnings to 17 companies that illegally sold more than 50 products claiming to prevent, treat or cure…

read more

‘Leaky’ blood vessels linked to Alzheimer’s

3500 2333 Peter Stevenson, PhD

Leaky blood vessels in the brain appear to be a driver of cognitive dysfunction in Alzheimer’s disease, a new study reports. The research, published in Nature Medicine, followed 161 older…

read more

Herpes and Alzheimer’s: Trigger or symptom?

1920 1280 Peter Stevenson, PhD

A new review article, published in Frontiers in Aging Neuroscience, has offered fresh evidence in support of a link between the Herpes Simplex Virus 1 (HSV1) and Alzheimer’s disease (AD).…

read more

Cognitive impairment in MS

2048 1153 Mea Holm, PhD

Up to 70% of MS patients suffer from cognitive decline, which often has a profound impact on an individual’s quality of life. It is little surprise that MS researchers are…

read more

Serum neurofilament light: A biomarker for disease activity in MS

1920 1080 Mea Holm, PhD

How close are we to establishing a reliable liquid biomarker for detecting disease onset, progression and treatment response in multiple sclerosis? According to Dr Peter Calabresi (Johns Hopkins, USA) at…

read more

Results from the MS-SMART trial unveiled

3971 2975 Mea Holm, PhD

Secondary progressive multiple sclerosis (SPMS) is known to be extremely difficult to treat; there are no effective therapies for halting or reversing disability progression in the late disease phase. In…

read more

De-risking PML: A conversation with Prof. Walter Atwood

2872 2598 Prof. Dr. Krassen Nedeltchev

We interviewed Professor Walter Atwood last week at the 2018 ECTRIMS congress in Berlin, Germany, to learn about advances in treating progressive multifocal leukoencephalopathy (PML) – an important treatment-associated infection…

read more

Fighting neurodegeneration in MS

3150 2100 Mea Holm, PhD

The pathology of multiple sclerosis (MS) involves not only the loss of myelin sheets around the axons of neurons, but also the fragmentation of the axons themselves. At ECTRIMS 2018,…

read more

FLOODLIGHT offers illuminating outcomes for smartphone monitoring in MS

1920 1080 Peter Stevenson, PhD

Smartphone-based, high-yield active and passive self-monitoring of multiple sclerosis (MS) may enhance clinical disease assessments when compared to conventional methods for detecting subtle progressive clinical changes, according to a study…

read more

New molecule could halt neural damage in Parkinson’s disease

2967 1980 Peter Stevenson, PhD

Researchers may have found a way to halt, and even reverse, the neural damage associated with Parkinson’s disease (PD) using a novel molecule that targets a key cause of nerve…

read more
Brainwork is supported by unrestricted grants from: